Navigation Links
MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016

DALLAS, January 9, 2012 /PRNewswire/ --

According to a new market research report, "Seed Treatment Market Trends and Global Forecasts (2011-2016)", published by MarketsandMarkets (, global seed treatment market is the fastest growing segment of crop protection market. This growth is fueled by government encouragement for adoption of seed treatment as crop protection practice. This growth is particularly higher in geographies such as Latin America and Asia-Pacific due to increased acceptance of GM seed and farmers awareness regarding maximum residue level.

Browse more than 143 market data tables/figures spread through more than 370 pages and in-depth TOC on "Seed Treatment Market Trends and Global Forecasts (2011-2016)".
Early buyers will receive 10% customization on reports.

With increasing concerns regarding crop protection, productivity and yields, expenses on crop protection are significantly increasing. Crop protection expense is the second highest expense after fertilizer in farming expenses. Thus expenses can be reduced by treating only the seeds as compared to the whole farm area with agrochemicals. Hence seed treatments is most cost effective way of protecting seeds and further crops from biotic and abiotic stresses.

Seed treatment chemicals, which includes seed treatment insecticides, fungicides and other seed treatment chemicals are biggest market segments as on 2010, owing to their wide-spread use in bulk quantities due to ease in availability, production, and application Chemical seed treatments currently control over 98% of global seed treatment market. Bio-control seed treatments are a smaller market segment, but expected to grow at a faster pace than any other segment, due to government encouragement to reduce agrochemicals usage.

The global seed treatment market [ ] reached to over $2250.0 million by the end of year 2010, and is expected to reach $3430.3 million by 2016, growing at a CAGR of 13.5% from 2011 to 2016. The North American market is expected to hold 22% of the global market share by 2016, at an estimated CAGR of 16.4% due to higher acceptance of GM seeds for soybean and maize/corn. Asia-Pacific is another fastest growing segment due to the constant push by government bodies for adoption of seed treatments with "100% seed treatment campaign". The market share of Asia-Pacific is expected to boost from $157.5 million in 2010 to $248.2 million by 2016, at an estimated CAGR of 14.4% from 2011 to 2016.

Some of the major drivers of the industry identified in this report are cost effectiveness of seed treatments, economic and social benefits, and increasing demand of GM seeds while major restraint is low shelf life of treated seeds.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages [ ], industrial automation, medical, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website

Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
MarketsandMarkets Blog @

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020
2. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
3. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
4. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
5. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
6. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
7. MarketsandMarkets: Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to Reach $5.6 Billion by 2015
8. MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
9. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
10. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
11. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... announced today that it has closed the sale of ... to Guerbet (GBT- NYSE Euronext) in a transaction valued ... four manufacturing facilities and a total of approximately 1,000 ... the St. Louis area. This ...
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
Breaking Biology Technology:
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):